Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Morsy
T A
TA
Essa
M H
MH
Aboul Anaan
A M
AM
Montasser
M F
MF
D000328:Adult; D000965:Antimony / Q000008:administration & dosage / Q000627:therapeutic use*; D000967:Antimony Sodium Gluconate / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005942:Gluconates / Q000627:therapeutic use*; D006801:Humans; D007271:Injections, Intradermal; D007896:Leishmaniasis / Q000188:drug therapy*; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D004113:Succimer / Q000008:administration & dosage / Q000627:therapeutic use*; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D005942:Gluconates; D009942:Organometallic Compounds; D013438:Sulfhydryl Compounds; D000965:Antimony; C004443:stibocaptate; D004113:Succimer; D000967:Antimony Sodium Gluconate